Eton Pharmaceuticals Inc [ETON] stock is trading at $14.68, down -3.99%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ETON shares have gain 4.11% over the last week, with a monthly amount drifted -10.57%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Eton Pharmaceuticals Inc [NASDAQ: ETON] stock has seen the most recent analyst activity on January 23, 2025, when H.C. Wainwright reiterated its Buy rating and also boosted its price target to $33 from $17. Previously, B. Riley Securities started tracking the stock with Buy rating on January 10, 2025, and set its price target to $21. On January 06, 2025, H.C. Wainwright reiterated its Buy rating and revised its price target to $17 on the stock. Craig Hallum initiated its recommendation with a Buy and recommended $8 as its price target on May 06, 2024. In a note dated January 04, 2021, H.C. Wainwright reiterated an Buy rating on this stock and revised its target price from $20 to $15.
Eton Pharmaceuticals Inc [ETON] stock has fluctuated between $3.03 and $18.41 over the past year. Currently, Wall Street analysts expect the stock to reach $13 within the next 12 months. Eton Pharmaceuticals Inc [NASDAQ: ETON] shares were valued at $14.68 at the most recent close of the market. An investor can expect a potential drop of -11.44% based on the average ETON price forecast.
Analyzing the ETON fundamentals
Eton Pharmaceuticals Inc [NASDAQ:ETON] reported sales of 34.68M for the trailing twelve months, which represents a growth of 46.90%. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at -0.15%, Pretax Profit Margin comes in at -0.15%, and Net Profit Margin reading is -0.16%. To continue investigating profitability, this company’s Return on Assets is posted at -0.15, Equity is -0.36 and Total Capital is -0.32. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 13.08 points at the first support level, and at 11.47 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.94, and for the 2nd resistance point, it is at 17.19.
Ratios To Look Out For
For context, Eton Pharmaceuticals Inc’s Current Ratio is 1.51. As well, the Quick Ratio is 1.41, while the Cash Ratio is 1.03. Considering the valuation of this stock, the price to sales ratio is 11.27, the price to book ratio is 23.73.
Transactions by insiders
Recent insider trading involved Opaleye Management Inc., 10% Owner, that happened on Oct 23 ’24 when 10000.0 shares were purchased. 10% Owner, Opaleye Management Inc. completed a deal on Oct 08 ’24 to buy 33970.0 shares. Meanwhile, 10% Owner Opaleye Management Inc. bought 16852.0 shares on Oct 04 ’24.
